Odyssean LLC’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.29M Buy
213,239
+29,732
+16% +$536K 0.5% 64
2026
Q2
$3.18M Buy
183,507
+70,589
+63% +$967K 0.52% 31
2026
Q1
$1.4M Buy
112,918
+54,226
+92% +$728K 0.51% 47
2025
Q4
$740K Buy
+58,692
New +$672K 0.53% 79

Other funds holding AMRX

Odyssean LLC's AMRX Position: Q3 2026 in Review

Odyssean LLC increased its Amneal Pharmaceuticals (AMRX) stake by 16% in Q3 2026, buying an estimated $536K and bringing the position to 213,239 shares worth $4.29M. The position accounts for 0.5% of the portfolio, ranked #64.

Odyssean LLC first reported a position in AMRX in Q4 2025 and has held it in 4 quarters since. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Odyssean LLC held 213,239 shares of Amneal Pharmaceuticals worth $4.29M as of Q3 2026.
  • Odyssean LLC bought 29,732 Amneal Pharmaceuticals shares in Q3 2026, an estimated $536K.
  • Amneal Pharmaceuticals made up 0.5% of Odyssean LLC's portfolio in Q3 2026, its #64 holding.
  • Odyssean LLC first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.